Hologic
Bookmark
ShareCopied to clipboardHologic is a company. It is a public company in Marlborough, the United States. It was founded in 1985 and its current CEO is Stephen P. MacMillan. It is part of the Health Care sector, specifically in the Health Care Equipment & Supplies industry.
Key facts
- city: Marlborough
- country: United States
- employees: 7,063 people
- revenues: 4B $
- company type: public
- sector: Health Care
- industry: Health Care Equipment & Supplies
- foundation year: 1985
- CEO: Stephen P. MacMillan
- ESG score: Try Pro to see estimate
See more facts
Extract data
Download datasets about Hologic:
Dataset of stocks from Hologic:
Hologic is one of the companies in the United States, companies in Health Care Equipment & Supplies, companies in Health Care, companies in Marlborough and 3,456,808 companies in our database.
Talking Points
- HologicDiscover the Science of Sure
- Hologic is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment.
- We're an innovative medical technology company w/ a passion for #womenshealth that drives us to enable healthier lives everywhere, every day.
- Enabling healthier lives, everywhere, every day. | We're an innovative medical technology company whose purpose is to enable healthier lives everywhere, every day. While we discover and develop groundbreaking products and services that benefit everyone, we are especially passionate about those that advance women's health and well-being.
- Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.